amfAR, The Foundation for AIDS Research
amfAR plays a vital role in AIDS research, identifying critical gaps in our knowledge of HIV and AIDS, and supporting groundbreaking studies that often lack the preliminary data required by more traditional funders.
New Krim Fellows will harness powerful technologies in support of HIV vaccine and latency studies.
Grants awarded through amfAR Fund to Fight COVID-19 will investigate “long-haulers” and effect of coronavirus on HIV reservoir.
A potentially groundbreaking clinical trial will test a combination HIV cure strategy.
While we remain firmly committed to curing HIV, amfAR is applying its experience and expertise to the fight against COVID-19.
Awards will support ‘Trojan horse’ approach to curing HIV and effort to unlock the secrets of post-treatment control.
amfAR’s ICISTEM researchers have been unable to find HIV in a pair of stem cell transplant patients who are off ART.
There are some things about curing HIV that you can only learn from people who have been cured.
New grant supports ambitious three-pronged attack on the HIV reservoir.
New research fellows harness powerful technologies in support of HIV vaccine and latency studies
amfAR’s Dr. Jeffrey Laurence publishes findings that could point the way to therapeutic interventions for COVID-19.